Crianza

← Biblioteca

guideline · 2021 · en

Medications for adolescents and young adults with opioid use disorder

Hadland SE, Aalsma MC, Akgül S, Alinsky RH, Bruner A, Chadi N, et al.

Journal of Adolescent Health 68(3):632-636

Evidencia · Alta
DOI · 10.1016/j.jadohealth.2020.12.129

Síntesis

Society for Adolescent Health and Medicine position paper on MOUD (medications for opioid use disorder) for adolescents/young adults. Strongly recommends buprenorphine or methadone as first-line for moderate-severe OUD, including in adolescents ≥16; notes systematic under-prescribing relative to need. Updated post-fentanyl-crisis: the once-controversial position is now consensus.

Etapas

12-18, transversal

Dominios

risk-behavior, health

Tags

opioid-use-disorder · buprenorphine · naltrexone · adolescents · sahm

Afirmaciones que citan esta fuente (1)